tiprankstipranks
Advertisement
Advertisement

AMLX Stock Latest News

Amylyx price target raised to $30 from $22 at BofA
The FlyAmylyx price target raised to $30 from $22 at BofA
4h ago
AMLX
Amylyx price target raised to $28 from $19 at Baird
PremiumThe Fly
Amylyx price target raised to $28 from $19 at Baird
3d ago
AMLX
Amylyx Maintained at Buy as Analyst Sees Strong Setup for LUCIDITY Trial; $34 Price Target Reaffirmed
PremiumRatings
Amylyx Maintained at Buy as Analyst Sees Strong Setup for LUCIDITY Trial; $34 Price Target Reaffirmed
3d ago
AMLX
Joseph Thome Reiterates Buy on Amylyx Ahead of Pivotal LUCIDITY Readout and $1.5B Peak Sales Opportunity for Avexitide
PremiumRatings
Joseph Thome Reiterates Buy on Amylyx Ahead of Pivotal LUCIDITY Readout and $1.5B Peak Sales Opportunity for Avexitide
3d ago
AMLX
Amylyx Pharmaceuticals Readies for Pivotal LUCIDITY Data
PremiumCompany Announcements
Amylyx Pharmaceuticals Readies for Pivotal LUCIDITY Data
4d ago
AMLX
Amylyx: Solid Balance Sheet and De-Risked Pipeline Support Buy Rating, $24 Price Target Maintained
PremiumRatingsAmylyx: Solid Balance Sheet and De-Risked Pipeline Support Buy Rating, $24 Price Target Maintained
4d ago
AMLX
Amylyx reports Q2 EPS (39c), consensus (36c)
Premium
The Fly
Amylyx reports Q2 EPS (39c), consensus (36c)
4d ago
AMLX
Amylyx sees cash runway into 2028
Premium
The Fly
Amylyx sees cash runway into 2028
4d ago
AMLX
Amylyx price target raised to $26 from $20 at Citi
PremiumThe Fly
Amylyx price target raised to $26 from $20 at Citi
7d ago
AMLX
Amylyx price target raised to $24 from $21 at Mizuho
PremiumThe Fly
Amylyx price target raised to $24 from $21 at Mizuho
21d ago
AMLX
Amylyx price target raised to $40, named a Best Idea at Guggenheim
PremiumThe Fly
Amylyx price target raised to $40, named a Best Idea at Guggenheim
2M ago
AMLX
Amylyx to present data from first-in-human, dose-ranging Phase 1 Lumina trial
PremiumThe Fly
Amylyx to present data from first-in-human, dose-ranging Phase 1 Lumina trial
2M ago
AMLX
Amylyx Shareholders Approve Directors, Auditor and Executive Pay
PremiumCompany AnnouncementsAmylyx Shareholders Approve Directors, Auditor and Executive Pay
2M ago
8K
AMLX
Amylyx announces publication of Phase 2 open-label HELIOS trial data
Premium
The Fly
Amylyx announces publication of Phase 2 open-label HELIOS trial data
3M ago
AMLX
Amylyx Pharmaceuticals Charts Path to 2026 Trial Data
Premium
Company Announcements
Amylyx Pharmaceuticals Charts Path to 2026 Trial Data
3M ago
AMLX
Buy Rating Reiterated on Amylyx as Avexitide Progress and Cash Runway Support Upside vs. Unchanged $24 Price Target
PremiumRatings
Buy Rating Reiterated on Amylyx as Avexitide Progress and Cash Runway Support Upside vs. Unchanged $24 Price Target
3M ago
AMLX
Amylyx reports Q1 EPS (37c), consensus (34c)
PremiumThe Fly
Amylyx reports Q1 EPS (37c), consensus (34c)
3M ago
AMLX
Amylyx sees cash runway into 2028
PremiumThe Fly
Amylyx sees cash runway into 2028
3M ago
AMLX
Amylyx announces launch of U.S. EAP for adults with PBH
PremiumThe Fly
Amylyx announces launch of U.S. EAP for adults with PBH
3M ago
AMLX
Amylyx’s ORION Trial in Progressive Supranuclear Palsy Reaches Completion: What Investors Should Watch
PremiumCompany AnnouncementsAmylyx’s ORION Trial in Progressive Supranuclear Palsy Reaches Completion: What Investors Should Watch
3M ago
AMLX
Amylyx price target raised to $21 from $19 at Mizuho
Premium
The Fly
Amylyx price target raised to $21 from $19 at Mizuho
3M ago
AMLX
Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
Premium
Ratings
Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential
4M ago
AMLX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >